Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

lilly cover image
$599
 Posted in: Dual/triple agonist Aug 05 | 2019Final Tirzepatide Pivotal Trial Initiated (SURPASS-5 add-on to basal insulin)Purchase Blast
BI and lilly cover image
$599
 Posted in: SGLT2i Aug 05 | 2019New Jardiance TV DTC Campaign ObservedPurchase Blast
tandem cover image
$599
 Posted in: Insulin Delivery Aug 01 | 2019Tandem Q2 '19 Earnings UpdatePurchase Blast
ADA cover image
$599
 Posted in: GLP-1RA, Glucose Monitoring Aug 01 | 2019ADA Standards of Care Update: REWIND, CGM TIR Targets, and Victoza PedsPurchase Blast
dexcom cover image
$599
 Posted in: Glucose Monitoring Jul 31 | 2019Dexcom Q2 '19 Earnings UpdatePurchase Blast
lexicon cover image
$599
 Posted in: SGLT2i Jul 31 | 2019Lexicon Comments on Partnership Termination; Lexicon Q2 '19 Earnings UpdatePurchase Blast
merck cover image
$599
 Posted in: DPP-IVi, SGLT2i Jul 30 | 2019Merck Q2 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, SGLT2i Jul 30 | 2019Empa T1DM Filed with FDA; Oral GLP-1RA Advanced to Ph1; Lilly Q2 '19 Earnings UpdatePurchase Blast
sanofi cover image
$599
 Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i Jul 29 | 2019Sanofi Q2 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: GLP-1RA Jul 29 | 2019No Update on REWIND CHMP DecisionPurchase Blast
sanofi and lexicon
$599
 Posted in: GLP-1RA, SGLT2i Jul 26 | 2019Sanofi Terminates Partnership with Lexicon for Sotagliflozin DevelopmentPurchase Blast
biocon cover image
$599
 Posted in: Basal Insulin, Bolus Insulin Jul 26 | 2019Biocon CY Q2 '19 (FY Q1 '20) Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: Glucagon Jul 26 | 2019FENIX Analysis: Baqsimi, Lilly’s Novel Nasal Glucagon Hypo Rescue ProductPurchase Blast
roche-cover image
$599
 Posted in: Glucose Monitoring, Other Jul 25 | 2019Roche Q2 '19 Earnings UpdatePurchase Blast
astrazeneca cover image
$599
 Posted in: DPP-IVi, GLP-1RA, SGLT2i Jul 25 | 2019DECLARE Approval Timeline Moved Up; AZ Q2 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: Glucagon Jul 24 | 2019Lilly Nasal Glucagon Approved As "BAQSIMI"Purchase Blast
glooko cover image
$599
 Posted in: Glucose Monitoring, Other Jul 23 | 2019Is Glooko Eying an IPO? New Partnership with Pack Health for Patient CoachingPurchase Blast
medtronic cover image
$599
 Posted in: Glucose Monitoring, Insulin Delivery Jul 23 | 2019Medtronic Files CGM for Non-Adjunctive ClaimPurchase Blast
european medicines agency cover image
$599
 Posted in: Bolus Insulin, DPP-IVi, GLP-1RA, Glucagon Jul 22 | 2019REWIND CHMP Decision This Week; CHMP Agenda HighlightsPurchase Blast
abbott cover image
$599
 Posted in: Glucose Monitoring Jul 17 | 2019Abbott Q2 '19 Earnings UpdatePurchase Blast
1 … 69 70 71 72 73 … 95

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In